These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 32539826

  • 1. Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya.
    Abudho BO, Guyah B, Ondigo BN, Ndombi EM, Ireri E, Carter JM, Riner DK, Kittur N, Karanja DMS, Colley DG.
    Infect Dis Poverty; 2020 Jun 15; 9(1):67. PubMed ID: 32539826
    [Abstract] [Full Text] [Related]

  • 2. Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study.
    Abudho BO, Ndombi EM, Guya B, Carter JM, Riner DK, Kittur N, Karanja DMS, Secor WE, Colley DG.
    Am J Trop Med Hyg; 2018 May 15; 98(5):1397-1402. PubMed ID: 29532768
    [Abstract] [Full Text] [Related]

  • 3. Cluster randomized trial comparing school-based mass drug administration schedules in areas of western Kenya with moderate initial prevalence of Schistosoma mansoni infections.
    Karanja DMS, Awino EK, Wiegand RE, Okoth E, Abudho BO, Mwinzi PNM, Montgomery SP, Secor WE.
    PLoS Negl Trop Dis; 2017 Oct 15; 11(10):e0006033. PubMed ID: 29059190
    [Abstract] [Full Text] [Related]

  • 4. Schistosoma mansoni Mass Drug Administration Regimens and Their Effect on Morbidity among Schoolchildren over a 5-Year Period-Kenya, 2010-2015.
    Sircar AD, Mwinzi PNM, Onkanga IO, Wiegand RE, Montgomery SP, Secor WE.
    Am J Trop Med Hyg; 2018 Aug 15; 99(2):362-369. PubMed ID: 29893197
    [Abstract] [Full Text] [Related]

  • 5. Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration.
    Crellen T, Walker M, Lamberton PH, Kabatereine NB, Tukahebwa EM, Cotton JA, Webster JP.
    Clin Infect Dis; 2016 Nov 01; 63(9):1151-1159. PubMed ID: 27470241
    [Abstract] [Full Text] [Related]

  • 6. Comparison of School-Based and Community-Wide Mass Drug Administration for Schistosomiasis Control in an Area of Western Kenya with High Initial Schistosoma mansoni Infection Prevalence: A Cluster Randomized Trial.
    Secor WE, Wiegand RE, Montgomery SP, Karanja DMS, Odiere MR.
    Am J Trop Med Hyg; 2020 Feb 01; 102(2):318-327. PubMed ID: 31802733
    [Abstract] [Full Text] [Related]

  • 7. Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors.
    Mueller A, Fuss A, Ziegler U, Kaatano GM, Mazigo HD.
    BMC Infect Dis; 2019 Oct 07; 19(1):832. PubMed ID: 31590657
    [Abstract] [Full Text] [Related]

  • 8. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.
    Shen Y, King CH, Binder S, Zhang F, Whalen CC, Evan Secor W, Montgomery SP, Mwinzi PNM, Olsen A, Magnussen P, Kinung'hi S, Phillips AE, Nalá R, Ferro J, Aurelio HO, Fleming F, Garba A, Hamidou A, Fenwick A, Campbell CH, Colley DG.
    BMC Infect Dis; 2017 Sep 29; 17(1):652. PubMed ID: 28962552
    [Abstract] [Full Text] [Related]

  • 9. Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood Schistosoma mansoni-Associated Morbidity: A Combined Analysis from the Schistosomiasis Consortium for Operational Research and Evaluation Cohort Studies in the Lake Victoria Regions of Kenya and Tanzania.
    Shen Y, Wiegand RE, Olsen A, King CH, Kittur N, Binder S, Zhang F, Whalen CC, Secor WE, Montgomery SP, Mwinzi PNM, Magnussen P, Kinung'hi S, Campbell CH, Colley DG.
    Am J Trop Med Hyg; 2019 Dec 29; 101(6):1336-1344. PubMed ID: 31407653
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of school-based preventive chemotherapy strategies for sustaining the control of schistosomiasis in Côte d'Ivoire: Results of a 5-year cluster randomized trial.
    Ouattara M, Diakité NR, Yao PK, Saric J, Coulibaly JT, Assaré RK, Bassa FK, Koné N, Guindo-Coulibaly N, Hattendorf J, Utzinger J, N'Goran EK.
    PLoS Negl Trop Dis; 2021 Jan 29; 15(1):e0008845. PubMed ID: 33449924
    [Abstract] [Full Text] [Related]

  • 11. SCORE Studies on the Impact of Drug Treatment on Morbidity due to Schistosoma mansoni and Schistosoma haematobium Infection.
    King CH, Binder S, Shen Y, Whalen CC, Campbell CH, Wiegand RE, Olsen A, Secor WE, Montgomery SP, Musuva R, Mwinzi PNM, Magnussen P, Kinung'hi S, Andrade GN, Ezeamama AE, Colley DG.
    Am J Trop Med Hyg; 2020 Jul 29; 103(1_Suppl):30-35. PubMed ID: 32400348
    [Abstract] [Full Text] [Related]

  • 12. Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses.
    Ndombi EM, Abudho B, Kittur N, Carter JM, Korir H, Riner DK, Ochanda H, Lee YM, Secor WE, Karanja DM, Colley DG.
    Parasite Immunol; 2018 Jun 29; 40(6):e12530. PubMed ID: 29604074
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia.
    Bajiro M, Dana D, Ayana M, Emana D, Mekonnen Z, Zawdie B, Garbi A, Kure A, Zeynudin A.
    Parasit Vectors; 2016 Oct 24; 9(1):560. PubMed ID: 27772528
    [Abstract] [Full Text] [Related]

  • 14. Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe.
    Mduluza T, Jones C, Osakunor DNM, Lim R, Kuebel JK, Phiri I, Manangazira P, Tagwireyi P, Mutapi F.
    PLoS Negl Trop Dis; 2020 Jun 24; 14(6):e0008388. PubMed ID: 32569278
    [Abstract] [Full Text] [Related]

  • 15. Increasing teacher motivation and supervision is an important but not sufficient strategy for improving praziquantel uptake in Schistosoma mansoni control programs: serial cross sectional surveys in Uganda.
    Muhumuza S, Katahoire A, Nuwaha F, Olsen A.
    BMC Infect Dis; 2013 Dec 13; 13():590. PubMed ID: 24330594
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.